Insulin resistance and intima–media thickness in the carotid and femoral arteries of clinically healthy 58‐year‐old men. The Atherosclerosis and Insulin Resistance Study (AIR)
暂无分享,去创建一个
[1] A. Astrup,et al. Obesity : Preventing and managing the global epidemic , 2000 .
[2] B. Fagerberg,et al. The euglycemic hyperinsulinemic clamp examination: variability and reproducibility. , 2000, Scandinavian journal of clinical and laboratory investigation.
[3] Eary,et al. CAROTID-ARTERY INTIMA AND MEDIA THICKNESS AS A RISK FACTOR FOR MYOCARDIAL INFARCTION AND STROKE IN OLDER ADULTS , 2000 .
[4] B. Fagerberg,et al. Computerized measurement of LDL particle size in human serum. Reproducibility studies and evaluation of LDL particle size in relation to metabolic variables and the occurrence of atherosclerosis. , 1999, Scandinavian journal of clinical and laboratory investigation.
[5] E. Randers,et al. Evaluation of the Dade Behring N Latex Cystatin C assay on the Dade Behring Nephelometer II System. , 1999, Scandinavian journal of clinical and laboratory investigation.
[6] C Schmidt,et al. How can the variability in ultrasound measurement of intima-media thickness be reduced? Studies of interobserver variability in carotid and femoral arteries. , 1999, Clinical physiology.
[7] R H Selzer,et al. The Role of Carotid Arterial Intima-Media Thickness in Predicting Clinical Coronary Events , 1998, Annals of Internal Medicine.
[8] A. Folsom,et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. , 1997, American journal of epidemiology.
[9] Arno W. Hoes,et al. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. , 1997, Circulation.
[10] E. Ferrannini,et al. Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR). , 1997, The Journal of clinical investigation.
[11] S. Haffner,et al. Insulin resistance implications for type II diabetes mellitus and coronary heart disease. , 1997, The American journal of medicine.
[12] P. D. de Feyter,et al. Atherosclerotic changes in the carotid artery bulb as measured by B-mode ultrasound are associated with the extent of coronary atherosclerosis. , 1997, Stroke.
[13] E. Bonora,et al. Intimal-Medial Thickness of the Carotid Artery in Nondiabetic and NIDDM Patients: Relationship with insulin resistance , 1997, Diabetes Care.
[14] N. Nishi,et al. Prevalence of asymptomatic carotid atherosclerotic lesions detected by high-resolution ultrasonography and its relation to cardiovascular risk factors in the general population of a Japanese city: the Suita study. , 1997, Stroke.
[15] P L Allan,et al. Relationship between carotid intima-media thickness and symptomatic and asymptomatic peripheral arterial disease. The Edinburgh Artery Study. , 1997, Stroke.
[16] S B Heymsfield,et al. Dual-energy X-ray absorptiometry body composition model: review of physical concepts. , 1996, The American journal of physiology.
[17] M. Matsuda,et al. Insulin resistance and coronary artery disease , 1996, Diabetologia.
[18] M. Laakso,et al. Femoral atherosclerosis in middle-aged subjects: association with cardiovascular risk factors and insulin resistance. , 1996, American journal of epidemiology.
[19] Y. Hara,et al. Insulin resistance as an independent risk factor for carotid wall thickening. , 1996, Hypertension.
[20] L. Berglund,et al. Prediction models for insulin resistance. , 1996, Blood pressure.
[21] M. Laakso. Insulin resistance and coronary heart disease , 1996, Current opinion in lipidology.
[22] J. Tobin,et al. The effect of age on insulin resistance and secretion: a review. , 1996, Seminars in nephrology.
[23] R. Bergman,et al. Increased Insulin Resistance and Insulin Secretion in Nondiabetic African-Americans and Hispanics Compared With Non-Hispanic Whites: The Insulin Resistance Atherosclerosis Study , 1996, Diabetes.
[24] R. Bergman,et al. Insulin Sensitivity and Atherosclerosis , 1996 .
[25] H. Lithell. Metabolic aspects of the treatment of hypertension , 1995, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.
[26] C. Sweet,et al. Safety and tolerability of losartan compared with atenolol, felodipine and angiotensin converting enzyme inhibitors , 1995, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.
[27] B. Fagerberg,et al. Carotid artery wall intima-media thickness is associated with insulin-mediated glucose disposal in men at high and low coronary risk. , 1995, Stroke.
[28] P M Rautaharju,et al. Arterial wall thickness is associated with prevalent cardiovascular disease in middle-aged adults. The Atherosclerosis Risk in Communities (ARIC) Study. , 1995, Stroke.
[29] B. Fagerberg,et al. Ultrasound evaluation of atherosclerotic manifestations in the carotid artery in high-risk hypertensive patients. Risk Intervention Study (RIS) Group. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.
[30] A. Hamsten,et al. Relation of Plasma Levels and Composition of Apolipoprotein B‐Containing Lipoproteins to Angiographically Defined Coronary Artery Disease in Young Patients With Myocardial Infarction , 1993, Circulation.
[31] J Ménard,et al. The 1993 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. , 1993, Blood pressure.
[32] Richard A. Kronmal,et al. Distribution and Correlates of Sonographically Detected Carotid Artery Disease in the Cardiovascular Health Study , 1992, Stroke.
[33] M L Bots,et al. Cardiovascular Determinants of Carotid Artery Disease: The Rotterdam Elderly Study , 1992, Hypertension.
[34] J. Salonen,et al. Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.
[35] M. Laakso,et al. Asymptomatic atherosclerosis and insulin resistance. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.
[36] H. Yki-Järvinen,et al. Severity, duration, and mechanisms of insulin resistance during acute infections. , 1989, The Journal of clinical endocrinology and metabolism.
[37] N. Na. 1989 Guidelines for the management of mild hypertension: memorandum from a WHO/ISH Meeting: , 1986 .
[38] R N Bergman,et al. Assessment of insulin sensitivity in vivo. , 1985, Endocrine reviews.
[39] R W Moore,et al. Readability of Self-Care Instructional Pamphlets for Diabetic Patients , 1981, Diabetes Care.
[40] K. Borner,et al. Enzymatische Bestimmung des Gesamtcholesterins mit dem Greiner Selective Analyzer (GSA-II) , 1977 .
[41] A. Wahlefeld. Triglycerides Determination after Enzymatic Hydrolysis , 1974 .
[42] R. Levy,et al. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.